Lost in Translation? Swiss Investigation into potential severe side-effects of Yaz
Yaz in the News:
As reported by Bloomberg News, in late September 2009, Swissmedic, the Swiss regulatory authority for drugs and medical devices, began an investigation into Yaz after a woman died from a pulmonary embolism while taking the birth control pill.
On October 22, 2009, Swissmedic released the results of its investigation but, unfortunately for us English-speakers, those findings were only released in German. Bayer was quick to offer their translation and issue a press release stating that “Swissmedic Sees No Higher Risk for Drospirenone Pills.” However, as Jim Edwards of BNET pointed out, upon further examination it isn’t clear that Bayer’s translation is 100% accurate.
From our understanding of the Swissmedic report, the study is still subject to peer review and a final report will be released at a later date with more information about the final results. In the meantime, if you are able to read German, feel free to take a look at the current report and let us know what you think.
